Literature DB >> 19189636

Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue.

Susanne Markert1, Silke Lassmann, Boris Gabriel, Maximilian Klar, Martin Werner, Gerald Gitsch, Felix Kratz, Annette Hasenburg.   

Abstract

BACKGROUND: The goal of this study was to evaluate the expression pattern and intracellular localization of alpha-folate receptor (alpha-FR) protein in human ovarian carcinoma compared with non-neoplastic ovarian tissue.
MATERIALS AND METHODS: Using immunohistochemistry (IHC), alpha-FR protein expression was analyzed in specimens of 104 human ovarian carcinomas and 30 non-neoplastic ovaries.
RESULTS: In 97% of the ovarian carcinomas, clear alpha-FR protein expression was detected (14% weak, 39% moderate, 44% strong). In the non-neoplastic ovaries, no (37%) or only weak (63%) expression was observed (p<0.0001). The tumor cells were characterized by a diffuse and homogeneous staining pattern. In tumor and non-tumor tissue, alpha-FR protein was detected predominantly in the cellular cytoplasm. In 41% of the ovarian carcinomas, cytoplasmic expression was localized towards the outer boarders of the invasive tumor cells and 30% exhibited additional nuclear alpha-FR protein expression.
CONCLUSION: Compared with nonneoplastic ovaries, alpha-FR protein is overexpressed in human ovarian carcinoma tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19189636

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  35 in total

Review 1.  Oncologic Procedures Amenable to Fluorescence-guided Surgery.

Authors:  Kiranya E Tipirneni; Jason M Warram; Lindsay S Moore; Andrew C Prince; Esther de Boer; Aditi H Jani; Irene L Wapnir; Joseph C Liao; Michael Bouvet; Nicole K Behnke; Mary T Hawn; George A Poultsides; Alexander L Vahrmeijer; William R Carroll; Kurt R Zinn; Eben Rosenthal
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

Review 2.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

3.  Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?

Authors:  Michael J Birrer; Ilaria Betella; Lainie P Martin; Kathleen N Moore
Journal:  Oncologist       Date:  2019-01-11

4.  Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy.

Authors:  Piriya Luangwattananun; Mutita Junking; Jatuporn Sujjitjoon; Yupanun Wutti-In; Naravat Poungvarin; Chanitra Thuwajit; Pa-Thai Yenchitsomanus
Journal:  Breast Cancer Res Treat       Date:  2021-01-03       Impact factor: 4.872

5.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.

Authors:  Gooitzen M van Dam; George Themelis; Lucia M A Crane; Niels J Harlaar; Rick G Pleijhuis; Wendy Kelder; Athanasios Sarantopoulos; Johannes S de Jong; Henriette J G Arts; Ate G J van der Zee; Joost Bart; Philip S Low; Vasilis Ntziachristos
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

6.  In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

Authors:  De-Gang Song; Qunrui Ye; Carmine Carpenito; Mathilde Poussin; Li-Ping Wang; Chunyan Ji; Mariangela Figini; Carl H June; George Coukos; Daniel J Powell
Journal:  Cancer Res       Date:  2011-05-05       Impact factor: 12.701

Review 7.  Exploiting the folate receptor α in oncology.

Authors:  Mariana Scaranti; Elena Cojocaru; Susana Banerjee; Udai Banerji
Journal:  Nat Rev Clin Oncol       Date:  2020-03-09       Impact factor: 66.675

8.  Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.

Authors:  Steven K Jones; Vincent Lizzio; Olivia M Merkel
Journal:  Biomacromolecules       Date:  2015-12-16       Impact factor: 6.988

9.  Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model.

Authors:  Steven K Jones; Kirk Douglas; Anthony F Shields; Olivia M Merkel
Journal:  Biomaterials       Date:  2018-06-13       Impact factor: 12.479

10.  A current review of targeted therapeutics for ovarian cancer.

Authors:  Susana M Campos; Sue Ghosh
Journal:  J Oncol       Date:  2010-01-03       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.